The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to saving lives and reducing the burden of disease in low and middle income countries (LMICs), while strengthening the capabilities of governments and the private sector in those countries to create and sustain high-quality health systems that can succeed without our assistance. For more information, please visit: http://www.clintonhealthaccess.org
Overview of CHAI’s Vaccines Program
To ensure all children have access to effective and affordable immunization, addressing the main causes of child mortality, CHAI’s Vaccines Markets Team works with vaccine manufacturers, Gavi and other global stakeholders to improve availability, affordability and diversity of supply for existing and future Gavi vaccines. In doing this, CHAI is applying the techniques it has used successfully to improve access to HIV/AIDS and malaria treatment: improving market demand transparency for individual suppliers, and working closely with these suppliers to optimize their commercial, costing and pricing strategies in LMIC markets, to ensure availability of vaccines, keep prices in these markets affordable, yet commercially sustainable.
As part of this work, CHAI is supporting Gavi and other stakeholders to improve access to vaccines for non-Gavi and former-Gavi middle income countries, through policy as well as supplier and country guidance on vaccine access and procurement. These middle-income countries sometimes lag behind lower income countries in introducing new vaccines, as they cannot rely on donor funding and visibility on access conditions for suppliers may be limited.
Close collaboration with CHAI’s country teams and global vaccine delivery team is critical in this area of work.
Since 2011, CHAI has worked in vaccine market shaping and has negotiated price reductions for major vaccines. For example, earlier work has resulted in a reduction in the price of rotavirus vaccine by two-thirds, resulting in savings of over USD$600M for global donors and governments over 5 years and a reduction in the price of pentavalent vaccine by 45%, generating savings of $150M over 4 years.
Some selected news articles about CHAI’s work on access in vaccines and other areas are listed here:
WHO press release, January 2018
WHO press release, April 2013
The pandemic context has only reinforced the importance of CHAI’s Vaccines Markets team’s work, coupling the need to ensure supply security for existing vaccines, for which demand and supply dynamics are being disrupted, with the need to accelerate time to market of a suitable COVID-19 vaccine on an unprecedented time frame. CHAI is working closely with many partners towards this goal.
Overview of CHAI Cambodia
CHAI began its partnership with the Cambodian Ministry of Health in 2005, and has since expanded to provide technical assistance, access to affordable commodities, and programmatic support to various national programs and departments including HIV, malaria, tuberculosis, COVID-19 response & medical oxygen, viral hepatitis, maternal and child health and vaccines.
CHAI, in partnership with Gavi, began supporting the National Immunization Program (NIP) of Cambodia through technical assistance to support building more robust programming and systems. We are pursuing three key objectives regarding (i) program planning, budgeting and financing at national and subnational level; (ii) enhancing data collection and reporting to guide decision-making; and (iii) support to the NIP and partners in the development of a full portfolio plan for Gavi’s 2022-2026 support. Since May 2021, CHAI has partnered with the Bill & Melinda Gates Foundation to support the Cambodian government to roll out COVID-19 vaccination.
Responsibilites
The Senior Associate will be part of the CHAI Vaccines team working to achieve affordable yet sustainable global vaccine prices and supply. The Senior Associate will report into the Cambodia team and work closely with the Global Vaccine Markets and Global Vaccines Delivery teams.
Responsibilities include but are not limited to the following:
Cambodia Country team
Support the preparation for and rollout of COVID-19 vaccines in line with the National Deployment Plan:
Provide analytical support to inform multi-year immunization prioritization and funding strategies for the Cambodian Expanded Programme on Immunization
Facilitate stakeholder discussions regarding planning for accelerated Gavi transition and increasing Gavi co-financing commitments
Global Vaccines Markets team
Contribute insights from LMICs to support supplier engagements (e.g., demand forecasting, supplier access strategies, regulatory access) and global/regional LMIC initiatives (e.g., Immunization Agenda 2030, UNICEF’s Vaccine Procurement Practitioners Exchange Forum)
Lead development of a robust understanding of decision-making processes for NVI (including for COVID-19), product switches, procurement processes and financing considerations in Cambodia and LMICs in the South East Asia region) and synthesize insights to become CHAI’s thought leader on vaccine procurement in the region
Pro-actively liaise between CHAI Global Vaccines Markets and Cambodia teams to share directional insights and proactively identify areas for deeper collaboration (e.g., to support Cambodia’s NVI priorities)
Lead development of effective working relationships with partners in Cambodia and LMICs in the region and support regional efforts to improve vaccines affordability and access
Prepare reports, presentations, and other analyses to inform global policy, supplier and country practices for enhanced vaccine procurement and access in LMICs
Coordinate the development and implementation of national and regional market access plans
Other
Qualifications
Advantages:
This vacancy is archived.